REFERENCES
- Abbott B. D., Perdew G. H., Buckalew A. R., Birnbaum L.S. Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by 2,3,7,8-tetrachlorodibenzo-p-dioxin and hydrocortisone. Toxicol. Appl. Pharmacol 1994; 128(1)138–150, [INFOTRIEVE], [CSA]
- Andreola F., Fernandez-Salguero P. M., Chiantore M. V., Petkovich M. P., Gonzalez F. J., De Luca L. M. Aryl hydrocarbon receptor knockout mice (AHR-/-) exhibit liver retinoid accumulation and reduced retinoic acid metabolism. Cancer Res 1997; 57(14)2835–2838, [INFOTRIEVE], [CSA]
- Baudry D., Faussillon M., Cabanis M. O., Rigolet M., Zucker J. M., Patte C., Sarnacki S., Boccon-Gibod L., Junien C., Jeanpierre C. Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour. Oncogene 2002; 21(36)5566–5573, [INFOTRIEVE], [CSA], [CROSSREF]
- Chellaiah M. A., Kizer N., Biswas R., Alvarez U., Strauss-Shoenberger J., Rifas L., Rittling S. R., Denhardt D. T., Hruska K. A. Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol. Biol. Cell 2003; 14(1)173–189, [INFOTRIEVE], [CSA], [CROSSREF]
- Dailly Y. P., Zhou Y., Linkhar T. A., Baylink D. J., Strong D. D. Structure and characterization of the human insulin-like growth factor binding protein (IGFBP)-6 promoter: identification of a functional retinoid response element. Biochim. Biophys. Acta (BBA) - Gene Structure and Expression 2001; 1518(1–2)145–151, [CSA], [CROSSREF]
- Duong Van Huyen J. P., Amri K., Baclair M. F., Vilar J., Merlet-Bacnichou C., Bruneval P., Leliavre-Pacgorier M. Spatiotemporal distribution of insulin-like growth factor receptors during nephrogenesis in fetuses from normal and diabetic rats. Cell Tissue Res 2003; 314(3)367–379, [INFOTRIEVE], [CSA], [CROSSREF]
- Englert C., Maheswaran S., Garvin A. J., Kreidberg J., Haber D. A. Induction of p21 by the Wilms' tumor suppressor gene WT1. Cancer Res 1997; 57(8)1429–1434, [INFOTRIEVE], [CSA]
- Falahatpisheh M. H., Ramos K. S. Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing. Oncogene 2003; 22(14)2160–2171, [INFOTRIEVE], [CSA], [CROSSREF]
- Falahatpisheh M. H., Ramos K. S. Ahr transcription factor regulates Wt1 at the post-transcriptional level and plays a role in nephrogenesis (in preparation). 2006, [CSA]
- Gonzalez F. J., Fernandez-Salguero P. The aryl hydrocarbon receptor. Studies using the Ahr-null mice. Drug Metab. Dispos 1998; 26(12)1194–1198, [INFOTRIEVE], [CSA]
- Hewitt S. M., Saunders G. F. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function. Anticancer Res 1996; 16(2)621–626, [INFOTRIEVE], [CSA]
- Hosono S., Luo X., Hyink D. P., Schnapp L. M., Wilson P. D., Burrow C. R., Reddy J. C., Atweh G. F., Licht J. D. WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene 1999; 18: 417–427, [INFOTRIEVE], [CSA], [CROSSREF]
- Ito K., Oji Y., Tatsumi N., Shimizu S., Kanai Y., Nakazawa T., Asada M., Jomgeow T., Aoyagi S., Nakano Y., Tamaki H., Sakaguchi N., Shirakata T., Nishida S., Kawakami M., Tsuboi A., Oka Y., Tsujimoto Y., Sugiyama H. Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway. Oncogene 2006; 25(30)4217–4229, [INFOTRIEVE], [CSA], [CROSSREF]
- Johnson C. D., Balagurunathan Y., Tadesse M. G., Falahatpisheh M. H., Brun M., Walker K. M., Dougherty E. R., Ramos K. S. Unraveling gene–gene interactions regulated by ligands of the aryl hydrocarbon receptor. Envir. Health Persp 2004; 112(4)403–412, [CSA]
- Kerkvliet N. I., Shepherd D. M., Baecher-Steppan L. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol. Appl. Pharmacol 2002; 185(2)146–152, [INFOTRIEVE], [CSA], [CROSSREF]
- Kreidberg J. A., Sariola H., Loring J. M., Maeda M., Pelletier J., Housman D., Jaenisch R. Wt1 is required for early kidney development. Cell 1993; 74: 679–691, [INFOTRIEVE], [CSA], [CROSSREF]
- Kuure S., Vuolteenaho R., Vainio S. Kidney morphogenesis: cellular and molecular regulation. Mech. of Develop. 2000; 92(1)31–45, [CSA], [CROSSREF]
- Mao M., Yu M., Tong J., Ye J., Zhu J., Huang Q., Fu G., Yu L., Zhao S., Waxman S., Lanotte M., Wang Z., Tan C. C., Tan J., Chan S., Chen Z. RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell. PNAS 1996; 93(12)5910–5914, [INFOTRIEVE], [CSA], [CROSSREF]
- Mimura J., Fujii-Kuriyama Y. Functional role of AhR in the expression of toxic effects by TCDD. Biochim. Biophys. Acta (BBA) - General Subjects 2003; 1619(3)263–268, [CSA], [CROSSREF]
- Mimura J., Yamashita K., Nakamura K., Morita M., Takagi T. N., Nakao K., Ema M., Sogawa K., Yasuda M., Katsuki M., Fujii-Kuriyama Y. Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes Cells 1997; 2(10)645–654, [INFOTRIEVE], [CSA], [CROSSREF]
- Murata Y., Kudoh T., Sugiyama H., Toyoshima K., Akiyama T. The Wilms tumor suppressor gene WT1 induces G1 arrest and apoptosis in myeloblastic leukemia M1 cells. FEBS Lett 1997; 409(1)41–45, [INFOTRIEVE], [CSA], [CROSSREF]
- Patterson L. T., Dressler G. R. The regulation of kidney development: New insights from and old model. Curr. Opin. Gene.t Dev 1994; 4: 696–702, [CSA], [CROSSREF]
- Puga A., Tomlinson C. R., Xia Y. Ah receptor signals cross-talk with multiple developmental pathways. Biochem. Pharmacol 2005; 69(2)199–207, [INFOTRIEVE], [CSA], [CROSSREF]
- Rigolet M., Faussillon M., Baudry D., Junien C., Jeanpierre C. Profiling of differential gene expression in Wilms' tumor by cDNA expression array. Ped. Nephrol. 2001; 16(12)1113–1121, [CSA], [CROSSREF]
- Scharnhorst V., van der Eb A. J., Jochemsen A.G. WT1 proteins: functions in growth and differentiation. Gene 2001; 273(2)141–161, [INFOTRIEVE], [CSA], [CROSSREF]
- Schedlich L. J., Graham L. D. Role of insulin-like growth factor binding protein-3 in breast cancer cell growth. Micro. Res. and Tech. 2002; 59(1)12–22, [CSA], [CROSSREF]
- Schmidt J. V., Su G. H.-T., Reddy J. K., Simon M. C., Bradfield C. A. Characterization of a murine Ahr null allele: Involvement of the Ah receptor in hepatic growth and development. PNAS 1996; 93(13)6731–6736, [INFOTRIEVE], [CSA], [CROSSREF]
- Singh S. U., Casper R. F., Fritz P. C., Sukhu B., Ganss B., Girard B., Jr., Savouret J. F., Tenenbaum H. C. Inhibition of dioxin effects on bone formation in vitro by a newly described aryl hydrocarbon receptor antagonist, resveratrol. J. Endocrinol 2000; 167(1)183–195, [INFOTRIEVE], [CSA], [CROSSREF]
- Sodek J., Zhu B., Huyng M. H., Brown T. J., Ringuette M. Novel functions of the matricellular proteins osteopontin and osteonectin/SPARC. Connect. Tissue Res 2002; 43(2–3)308–319, [INFOTRIEVE], [CSA]
- Soprano D. R., Soprano K. J. Pharmacological doses of some synthetic retinoids can modulate both the aryl hydrocarbon receptor and retinoid receptor pathways. J. Nutr 2003; 133(1)277S–281, [INFOTRIEVE], [CSA]
- Wagner K. D., Wagner N., Schedl A. The complex life of WT1. J. Cell Sci 2003; 116(9)1653–1658, [INFOTRIEVE], [CSA], [CROSSREF]
- Werner H., Roberts C. T., Rauscher F. J., LeRoith D. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1. J. Mol. Neurosci 1996; 7(2)111–123, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang X., Xing G., Saunders G. F. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1. Anticancer Res 1999; 19(3A)1641–1648, [INFOTRIEVE], [CSA]